Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase.
about
Isolation and characterization of cDNA clones for human apolipoprotein A-ICharacterisation of mRNAs encoding the precursor for human apolipoprotein CIConformational studies of the N-terminal lipid-associating domain of human apolipoprotein C-I by CD and 1H NMR spectroscopyAmino acid sequence of human plasma apolipoprotein C-III from normolipidemic subjectsComputational lipidology: predicting lipoprotein density profiles in human blood plasmaRat apolipoprotein A-IV contains 13 tandem repetitions of a 22-amino acid segment with amphipathic helical potentialIncreased response to cholesterol feeding in apolipoprotein C1-deficient miceCombination of 'omics' data to investigate the mechanism(s) of hydrazine-induced hepatotoxicity in rats and to identify potential biomarkers.APOC1 T45S polymorphism is associated with reduced obesity indices and lower plasma concentrations of leptin and apolipoprotein C-I in aboriginal CanadiansIsoforms of apolipoprotein C-I associated with individuals with coronary artery disease.Decreased serum apolipoprotein A-I concentrations in cows infected with Salmonella typhimurium.A phenomics-based strategy identifies loci on APOC1, BRAP, and PLCG1 associated with metabolic syndrome phenotype domains.Familial apolipoprotein AI and apolipoprotein CIII deficiency. Subclass distribution, composition, and morphology of lipoproteins in a disorder associated with premature atherosclerosis.Mechanism of action of gemfibrozil on lipoprotein metabolism.The solid phase synthesis of a protein activator for lecithin-cholesterol acyltransferase corresponding to human plasma apoC-IPlasma high density lipoprotein is increased in man when low density lipoprotein (LDL) is lowered by LDL-pheresis.The lipoprotein abnormality in Tangier disease: quantitation of A apoproteinsPlasma apolipoproteins and lipids in normal persons and patients with hypertensionConstitutive inhibition of plasma CETP by apolipoprotein C1 is blunted in dyslipidemic patients with coronary artery disease.Apolipoprotein A-I modulates processes associated with diet-induced nonalcoholic fatty liver disease in miceActivation of lecithin:cholesterol acyltransferase by a synthetic model lipid-associating peptide.Intestinal apoproteins during fat absorption.An Evaluation of the Crystal Structure of C-terminal Truncated Apolipoprotein A-I in Solution Reveals Structural Dynamics Related to Lipid Binding.Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone.Different cis-acting DNA elements control expression of the human apolipoprotein AI gene in different cell types.The carboxy-terminal region of apoA-I is required for the ABCA1-dependent formation of alpha-HDL but not prebeta-HDL particles in vivo.Changes in helical content or net charge of apolipoprotein C-I alter its affinity for lipid/water interfaces.Properties of the plasma very low and low density lipoproteins in Tangier disease.ApoE and ApoC-I polymorphisms: association of genotype with cardiovascular disease phenotype in African AmericansHyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1.A novel estrogen-regulated avian apolipoprotein.Identification of a cDNA clone for mouse apoprotein A-1 (apo A-1) and its use in characterization of apo A-1 mRNA expression in liver and small intestine.Intracellular and extracellular processing of human apolipoprotein A-I: secreted apolipoprotein A-I isoprotein 2 is a propeptide.HDL quality and functionality: what can proteins and genes predict?The potential of cholesteryl ester transfer protein as a therapeutic target.Advances in high-density lipoprotein physiology: surprises, overturns, and promises.High-density lipoprotein (HDL) metabolism and bone mass.Impact of genetic deletion of platform apolipoproteins on the size distribution of the murine lipoproteome.Lipoprotein-X: a substrate for lecithin: cholesterol acyltransferase.Lipid substrates for LCAT activity in liver disease.
P2860
Q24628901-AEA853A6-5D8A-4DA3-BCEB-91EFA7C16193Q24635223-E6D1638D-9CE1-41C7-89AE-9D7C6DC475F4Q24673369-469846AE-A05A-40F4-9323-26ECB5925D50Q28307638-2D616888-97C7-4954-8A3E-D663CAF765C7Q28472676-9AFFEC80-478D-4886-A090-E900685668E7Q28570053-5C49A50E-AEA8-47A4-8FB2-544EE5F18FF4Q28587768-66DD1693-51AF-4DBF-9F6D-C565DC9FD558Q30959523-59D9C6E4-A7D6-49CC-8C64-5EC45989DEECQ33741245-1A87C5AD-99C4-4A5B-B10E-363E57BB417BQ33780780-07B7FE0C-C863-4A73-97DC-FE48FBF548F6Q33923161-9211F8A3-E452-46AC-AFE5-83D5F5CF685BQ34055370-73847F80-6F72-4F2D-A2F4-8E1CC14C0D6AQ34618931-D4502989-AB5A-42FF-AFD1-F261A231F908Q34628487-714443C0-945A-497B-89BF-CFE98E1B6937Q35000063-1B8AC2BE-8B46-406D-8A92-5C732FDD81F0Q35589058-4B6692E2-F74C-49CD-9E75-D2423E1A1454Q35906192-8219E424-D05B-4C58-9C56-ED5E20FFA8D4Q35954157-CD2407AE-9410-4DEA-BC68-5A81A4C5D735Q35958497-76BED547-9BB2-4CB8-8489-F0575F10DFC7Q36283410-4E3AF702-068B-40D4-B334-116477B028CFQ36391865-E5B835BB-EA0E-4FCE-ABB8-C103E7341E1DQ36461665-B7C87803-2D14-447F-A1F1-02291C9C1114Q36650430-FDF09BBF-0A31-4C04-B656-A086F7785D82Q36745091-E0725678-F6E5-4655-8C3A-5A3063B99C82Q36782760-F723C81B-8030-4CC5-BBCD-4E4C3EEC3BDFQ36859049-9047ADA9-C7F5-4BCC-A276-4B6E6D79167DQ36920606-3AC32383-419D-4492-8212-85A2307626AEQ37049858-517CE277-6692-4BEB-81FE-CF6B85C93D83Q37222426-1692E6F3-2CF7-431F-BD28-7B33D438A4B4Q37376984-2AE30B50-29E9-4AE2-A8B0-D8AA10930741Q37501686-374AD0E2-1C09-4EEA-BF3A-92DFCA91C5E7Q37605992-9A7E5E9A-1509-48AC-A939-39780B259B93Q37610300-175193F0-804B-4481-BBA9-8157727035A7Q38197735-1320DBFC-DE1F-4B90-BBE3-6705B7D6E787Q38554684-6B7BE175-0114-4BF7-98C9-A2BA018540F1Q38623588-482B1842-BD2A-4440-BECC-2DEBD784289BQ38743436-3A4CBA5D-1DB6-4D58-A2AC-76BDE45F6265Q39626162-6A79A3F7-103E-4847-91CA-2FFC2ADB3059Q40090380-1BE4E855-3CCE-45EF-B638-8AC935D20E06Q40120446-A06B1E76-AA0B-474A-939A-2B7486E2983C
P2860
Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
Effect of the human plasma apo ...... : cholesterol acyltransferase.
@en
Effect of the human plasma apo ...... : cholesterol acyltransferase.
@nl
type
label
Effect of the human plasma apo ...... : cholesterol acyltransferase.
@en
Effect of the human plasma apo ...... : cholesterol acyltransferase.
@nl
prefLabel
Effect of the human plasma apo ...... : cholesterol acyltransferase.
@en
Effect of the human plasma apo ...... : cholesterol acyltransferase.
@nl
P2093
P356
P1433
P1476
Effect of the human plasma apo ...... : cholesterol acyltransferase.
@en
P2093
Jackson RL
Sparrow JT
P304
P356
10.1021/BI00685A003
P407
P577
1975-07-01T00:00:00Z